← Eichor
Condition: Rectal Cancer Stage Iii Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Rectal Cancer Stage Iii

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Pa
Phase 3 · 60 location(s) · ECOG-ACRIN Cancer Research Group · NCT05863195Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer
Phase N/A · 1 location(s) · Gene Solutions · NCT06589388Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
Phase 1 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04703101Efficacy and Toxicity of Total Neoadjuvant Sandwich Treatment Via Short Course Radiotherapy in the Treatment of Stage II
Phase 2 · 1 location(s) · Ain Shams University · NCT07095439Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cance
Phase 3 · 1 location(s) · Fudan University · NCT05954078A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally
Phase 2/Phase 3 · 2 location(s) · Suzhou Suncadia Biopharmaceuticals Co., Ltd. · NCT07454720Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06834126Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression
Phase 2 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT07176182Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cem
Phase 1/Phase 2 · 6 location(s) · National Cancer Institute (NCI) · NCT07147231UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer
Phase 4 · 1 location(s) · Zhejiang Cancer Hospital · NCT05148767MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer
NA · 1 location(s) · Sun Yat-sen University · NCT06204484Family Communications After Genetic Testing
NA · 276 location(s) · Alliance for Clinical Trials in Oncology · NCT07143487Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
Phase 2/Phase 3 · 16 location(s) · Centre Hospitalier Universitaire de Besancon · NCT05462613Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
NA · 1 location(s) · Fred Hutchinson Cancer Center · NCT06802172The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
Phase N/A · 1 location(s) · Case Comprehensive Cancer Center · NCT04624555Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery
Phase 2/Phase 3 · 4 location(s) · Sir Mortimer B. Davis - Jewish General Hospital · NCT03051464Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cance
NA · 13 location(s) · City of Hope Medical Center · NCT07125729CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With
Phase 2 · 1 location(s) · Northwestern University · NCT05733000Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or G
Phase 1 · 1 location(s) · Roswell Park Cancer Institute · NCT04511039Hyperthermia With Chemoradiotherapy in Rectal Cancer
NA · 2 location(s) · University Hospital Tuebingen · NCT06831981FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT06780787PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT05236972Clinical Research on the Treatment Model of Ambulatory Surgery for Colorectal Cancer
NA · 1 location(s) · First Hospital of China Medical University · NCT06637215Rectal Cancer CTC Trial
NA · 4 location(s) · University Hospital Ostrava · NCT07194616Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer
Phase 2 · 1 location(s) · Lithuanian University of Health Sciences · NCT05378919A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer
Phase 3 · 6 location(s) · Jiangsu Simcere Pharmaceutical Co., Ltd. · NCT07361003Early Detection of Advanced Adenomas and Colorectal Cancer
Phase N/A · 6 location(s) · City of Hope Medical Center · NCT06342440A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Ne
Phase 3 · 1 location(s) · Tao Zhang · NCT07113275Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
Phase 3 · 1 location(s) · Roswell Park Cancer Institute · NCT06563388
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.